Revolutionary Science Meets Transformative Cancer Therapy
Seattle Genetics Completes Acquisition of Cascadian Therapeutics
From Promise to Therapy
Seattle Genetics is conducting clinical trials in these and other therapeutic areas:
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
- Urothelial cancer
- Breast cancer
Join The Seattle Genetics Team
We are a group of passionate innovators dedicated to positively impacting the lives of those living with cancer, and we're always looking to add to our team.
Recent News
Seattle Genetics At A Glance
| Year founded | 1998 |
|
| Global Headquarters | Bothell, WA |
|
| Nasdaq | SGEN |
|
| Number of Employees | ~1,200 |
|
| Clinical & preclinical pipeline programs | 12+ |
|
| ADCs in clinical trials using our technology | 20+ |
|
-
"We believe our promising late-stage programs will drive future growth for the company and enable us to achieve our… twitter.com/i/web/status/9… · 4 minutes ago
-
SGEN 1Q financial results announced here ow.ly/AvYQ30jHtnw & today’s webcast at 1:30pm PT/4:30pm ET ow.ly/Gk8330jHqxd · 35 minutes ago
-
We're proud to sponsor @LivingBeyondBC and the #lbbcmetsconf. Come visit our booth for more info on our tucatinib H… twitter.com/i/web/status/9… · 5 days ago
